Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English Filtered by asset MTSR
Coverage 92,670 Raw stories ingested 8,002 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 Live Pipeline agents
  • FMP Stock News Fetch every minute running now
  • FMP Forex News Fetch every 5 min 5m ago
  • CoinGecko News Fetch every 5 min 5m ago
  • FIO Stock News Fetch every 10 min 4m ago
  • Patria Stock News Fetch every 10 min 4m ago
  • Editorial rewrite Rewrite every minute 1m ago
  • Asset sync Assets every 1 hour 24m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-07-20 14:20 6d ago
2026-07-20 09:02 6d ago
Railpen lifts IP Group offer with cash, Nanopore stake and Metsera upside
MTSR Metsera
FMP Stock News
Original source text
Railpen has raised its takeover proposal for IP Group PLC (LSE:IPO), offering shareholders a mix of cash, shares in Oxford Nanopore and a contingent payout linked to the biotech firm Metsera.

The pension fund manager, IP Group's largest shareholder with an 18.4% stake, has made two improved proposals to the board since its initial approach on 22 June, following meetings with shareholders and directors.

Under the latest terms, IP Group shareholders would receive 61p in cash for each share held.

They would also get a pro rata share of the company's entire holding in Oxford Nanopore Technologies, worth 10.6p per IP Group share based on Nanopore's closing price of 115.9p on the last business day before the announcement.

In addition, shareholders would receive a contingent value right worth up to 11.3p per share, linked to the value of IP Group's interest in Metsera as at the end of 2029, or earlier if the stake is sold.

The Metsera interest had a net asset value of £128.2 million at the end of 2025.

The contingent value right would pay 30% of any increase above that level by the end of 2029, subject to a 10% annual return hurdle, implying a net asset value hurdle of £170.6 million.

Railpen cautioned there is no certainty that any uplift in Metsera's value will occur or that any payment will be made.

The proposal remains subject to pre-conditions including formation of a consortium, confirmatory due diligence, and a unanimous, unconditional recommendation from the IP Group board.
2026-06-11 17:16 1mo ago
2026-03-17 04:46 4mo ago
IP Group shares jump 9% as Metsera deal drives return to growth
MTSR Metsera
FMP Stock News
Original source text
Shares in IP Group PLC (LSE:IPO) rose 9% to 53.5p on Tuesday after the company reported net asset value per share climbing to 110.4p, with total NAV reaching £975.1 million.

The recovery was driven largely by Pfizer's acquisition of Metsera, a biotechnology company developing obesity treatments.

The deal brought £128.2 million in discounted future royalty and milestone income onto IP Group's balance sheet, giving it direct financial exposure to Pfizer's obesity drug programme, including a phase III trial of PF'3944, a GLP-1 therapy.

Portfolio companies raised a combined £914 million during the year, up 17%, with notable rounds including $115 million for DNA repair drug developer Artios and $103 million for autonomous vehicle software company Oxa.

Cash proceeds from exits fell to £68.1 million, down from £183.4 million in 2024.

The group completed a £75 million buyback, retiring roughly 9% of its share capital, and is targeting more than £250 million in portfolio exits by end-2027.